Boundless Bio Makes $100M IPO Debut on Nasdaq
Precision oncology company Boundless Bio is set to go public with a $100 million IPO on the Nasdaq, trading under ...
- Latest
- Trending
Precision oncology company Boundless Bio is set to go public with a $100 million IPO on the Nasdaq, trading under ...
Moleculin Biotech's stock has been given a "sell" rating by a firm, with a 1-year low of $4.34 and a ...
Atticus Wealth Management LLC buys stake in Moleculin Biotech as the firm sets a “sell” rating on the stock; MBRX ...
NextCure, Inc. (NXTC) is a biopharmaceutical company focused on novel immunomedicines. Strong financials, positive outlook, and promising pipeline.
Discover the financial report of Theratechnologies Inc., a biopharmaceutical company specializing in healthcare therapies. Learn about their market cap, leadership ...
Exciting news from Adam Feuerstein! His informative and spicy newsletter will debut tomorrow. Brazilian government aiming to reduce healthcare costs ...
Published results show a 36-month survival rate of 20% with immunotherapy. ICI resistant group had a 72% 12-month OS rate. ...
South Korean conglomerate LG Corp. plans to invest $10 billion in artificial intelligence and battery production for electric vehicles.
Microsoft is placing a big bet on AI, especially through its partnership with OpenAI. The impact on the company's reputation ...
Journe auctions unique Élégante timepiece to raise funds for breast cancer research. Watch features pink accents and benefits Breast Cancer ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.